Mallinckrodt Clinical Trials
Sponsors / Mallinckrodt
The ClinicalTrials.gov registry records 133 trials led by Mallinckrodt. 0 trials are actively recruiting participants, 1 remain active without open enrollment, and 95 have concluded. 29 of these trials ended early via termination or withdrawal. The most common reasons cited for termination include slow or insufficient recruitment, business or strategic decisions. The cumulative planned enrollment figure across all listed trials is 11,770 participants. All figures are drawn directly from ClinicalTrials.gov and updated as sponsors submit revisions.
133
Total Trials
0
Recruiting
1
Other Active
95
Completed
29
Terminated / Withdrawn
11,770
Total Enrollment
Termination reasons: Recruitment41% · Other28% · Business14% · Safety10% · Efficacy3% · Funding3%
Recent Terminations
- NCT02523092 Stopped Jan 2025Sarcoidosis"sponsor closed study down"
- Recovery Following Cholecystectomy"The study was halted due to the worldwide COVID-19 pandemic and the cancellation of all elective cases."
- Panuveitis"Logistical challenges; no safety concerns"
- Multiple Sclerosis"Slow enrollment"
- NCT03132428 Stopped Feb 2020Pulmonary Hypertension of Newborn"Positive results at interim analysis"
- Amyotrophic Lateral Sclerosis"As recommended by the study's independent Data and Safety Monitoring Board (DSMB)"
- Acute Pain"Business decision"
- Uveitis
- Acute Pain, Postoperative"Business decision because enrollment was slower than expected"
- Post Operative Pain
Active Trials (1 total)
- Stroke PHASE2NCT03023449